Kura Oncology, Inc. (KURA)
8.655
-0.18
(-1.98%)
USD |
NASDAQ |
Apr 29, 11:36
Kura Oncology Research and Development Expense (TTM) : 251.07M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Abbott Laboratories | 2.943B |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Lexicon Pharmaceuticals, Inc. | 60.50M |
| Viemed Healthcare, Inc. | 3.017M |
| Liquidia Corp. | 38.35M |